Skip to content

Whitehawk Therapeutics, Inc.

WHWK

CIK 0001422142

← back to feed
Revenue (TTM)
$7.15M
−72.5% YoY Q1 May 2026
Net Income (TTM)
−$19.54M
+67.7% YoY Q1 May 2026
EPS Diluted (TTM)
$0.49
+86.0% YoY Q1 May 2026
Gross Margin
89.4%
Q1 May 2026
Operating Margin
-1,582.0%
Q1 May 2026
Net Margin
-273.5%
Q1 May 2026
Free Cash Flow (TTM)
−$77.69M
Q1 May 2026
Cash
$34.79M
Q1 May 2026
Total Debt
—
Q1 May 2026
Shares Outstanding
49.45M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings